- Cultured tree shrew UCMSCs were observed under a light microscope (Figure 1A), and GFP-labeled tree shrew UCMSCs were observed under a fluorescence microscope (Figure 1B).
The cultured tree shrew UCMSCs grew fibrously, were evenly distributed, and grew adherently. The cells were observed with a fluorescence microscope, and the cells were shown to have GFP yellow-green fluorescence.
- Tree shrew body temperature observation after modeling.
The body temperature of the tree shrews began to rise one day after the model was made and reached a maximum of 41.3 degrees 10 days after the model was made (Figure 2).
- Tree shrew white blood cell count after modeling.
The tree shrew white blood cell count began to increase 1 day after modeling and reached a maximum of 8.91 × 109/L 4 days after modeling (Figure 3).
- The distribution of fluorescent cells in each organ 2 days after tree shrews were infused with cells.
Two days after the tree shrew infusion of cells, each organ was frozen and sectioned, and the nuclei were stained with DAPI, which generated blue fluorescence, and the cells imported into the body carried green fluorescence, representing the distribution of transplanted cells. Two days after the infusion of the UCMSCs, the distribution of fluorescent cells in the pancreatic tissue was more obvious. A small number of fluorescent cells were distributed in other tissues (Figure 4).
- The distribution of fluorescent cells in each organ 10 days after tree shrews were infused with cells.
Ten days after the infusion of cells into the tree shrew, the distribution of fluorescent cells in the liver tissue was more obvious. There was a certain amount of fluorescent cell distribution in other tissues (Figure 5).
- The distribution of fluorescent cells in each organ in model tree shrews that were not returned with cells.
The model tree shrew with unreturned cells showed no distribution of fluorescent cells in each tissue (Figure 6).
- HE staining results in various organs in the model group, treatment group and control group (Figs. 7-11):
7.1. HE staining of the heart showed that the model group showed more myocardial fiber edema and loose cytoplasmic staining (black arrow), and the treatment group recovered to near the normal level of the control group (Figure 7).
7.2. Liver HE staining showed that there was more hepatocyte edema in the model group, cytoplasmic loose staining (black arrow), a small amount of hepatocyte edema resembling balloon-like degeneration, cell swelling, nuclear centering, and cytoplasmic vacuolization (yellow arrow). A small amount of lymphocyte infiltration (red arrow) was seen around the bile duct in the local portal area. The treatment group returned to near the normal levels of the control group (Figure 8).
7.3. The spleen HE staining results showed that the spleen nodules in the model group mostly had lymphocyte spotted necrosis, deep stenosis or fragmentation (black arrow). A small amount of extramedullary hematopoietic foci (yellow arrow) was seen in the red pulp. The treatment group returned to near the normal level of the control group (Figure 9).
7.4. HE staining results showed that a large amount of alveolar wall thickening was observed in the model group, accompanied by a large number of lymphocytes and neutrophil infiltration (black arrow), more alveolar wall epithelial cell necrosis, and nuclear fragmentation (yellow arrow). The treatment group returned to near the normal level of the control group (Figure 10).
7.5. Renal HE staining showed that the model group had a small increase in glomerular matrix (black arrow). Renal tubular dilatation was observed in the renal cortex. More lymphocytic focal infiltration was observed in the renal medulla (yellow arrow). The treatment group returned to near the normal level of the control group (Figure 11).
7.6. Intestinal HE staining results showed that the model group showed spot gland necrosis of individual gland cells (black arrow), cytoplasmic vacuolation, and nucleus shrinkage; scattered neutrophils (blue arrow) were seen in the lamina propria. The treatment group returned to close to the normal control group (Figure 12).
7.7. The results of pancreas HE staining showed that some pancreatic islets in the model group showed nucleus contraction (blue arrow) of individual pancreatic islet cells, and the staining was deepened. The treatment group returned to close to the normal control group (Figure 13).
8. Results of renal PAS and Masson staining in the model group, treatment group and control group (Figure 14):
Kidney PAS staining of the model group showed more common glomerular basement membrane thickening (black arrow). The treatment group had renal PAS staining. There was no significant thickening of the glomerular basement membrane. Kidney Masson staining of the model group showed a small amount of collagen fiber hyperplasia (black arrow) in the tissue. In the treatment group, kidney Masson staining with no collagen fiber proliferation was observed. The treatment group recovered to near the normal control group.
9. Test results of inflammatory factors in the model group, normal control group and treatment group:
9.1. TNF-α test results of the 3 groups:
TNF-α increased in the model group and decreased after treatment (Figure 15).
9.2. IL-6 test results of the 3 groups:
IL-6 increased in the model group and decreased after treatment (Figure 16).
9.3. IL-10 test results of the 3 groups:
IL-10 decreased in the model group and increased after treatment (Figure 17).
10. Results of liver function, renal function and heart function tests in the model group, normal control group and treatment group:
10.1 Results of renal function tests in the three groups (Figure 18): Urea and creatinine in the model group were significantly increased and were significantly reduced after treatment.
10.2 Results of liver function tests in the three groups (Figure 19): The model group had significant increases in alanine aminotransferase and aspartate aminotransferase, which were significantly reduced after treatment.
10.3 Results of heart function tests in the three groups (Figure 20): The creatine kinase and phosphocreatine kinase isoenzymes in the model group were significantly increased and were significantly reduced after treatment.